Plasmodium falciparum News and Research

RSS

Scientists demonstrate feasibility of preventing malaria parasite from becoming sexually mature

Researchers have demonstrated the possibility of preventing the human malaria parasite, Plasmodium falciparum, which is responsible for more than a million malaria deaths a year, from becoming sexually mature.

5 Jun 2008

FSU research may speed new malaria treatments, vaccines for children

April 25 is World Malaria Day 2008 and despite the grim statistics out of Africa there's cause for celebration. Florida State University biologists have discovered an autoimmune-like response in blood drawn from malaria-infected African children that helps to explain why existing DNA-based anti-malaria vaccines have repeatedly failed to protect them.

23 Apr 2008

New inexpensive test for malaria detection

ETH Zurich professor Peter Seeberger has been working on a sugar-based malaria vaccine for years.

4 Mar 2008

Could a simple vitamin A and zinc supplement help protect young children from malaria?

A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.

7 Feb 2008

New genetic findings on malaria parasite

The malaria parasite has been studied for decades, but surprisingly, little is known about how it behaves in humans to cause disease.

29 Nov 2007

Whole parasite malaria vaccine to be manufactured for clinical trials

Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.

29 Oct 2007

Malaria remains formidable challenge in the Americas

Malaria remains a formidable challenge for the countries of the Americas and more action is needed to improve national control programs to reduce the burden of the disease, health ministers from the Americas heard today.

8 Oct 2007

New understanding of the malarial parasite

About 2 million people die of malaria every year, of which more than a million are children in sub-Saharan Africa.

17 Sep 2007

Sugar key to malaria parasite invasion

Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified a sugar in mosquitoes that allows the malaria-causing parasite, Plasmodium falciparum, to attach itself to the mosquito's gut.

11 Sep 2007

Researchers look at malaria resistance to chloroquine

Funded by a $1.5 million grant from the National Institutes of Health (NIH), scientists at Binghamton University, State University of New York, hope to understand how the malaria parasite Plasmodium falciparum evolved resistance to the once-effective medication chloroquine.

3 Sep 2007

Start of Phase II trial of intravenous artesunate for children with severe malaria

A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September.

30 Aug 2007

Binghamton University researchers investigate evolving malaria resistance

Funded by a $1.5 million grant from the National Institutes of Health, scientists at Binghamton University, State University of New York, hope to understand how the malaria parasite Plasmodium falciparum evolved resistance to the once-effective medication chloroquine.

30 Aug 2007

Discovery of mechanism in malaria parasite that helps it adapt to infected individuals

Plasmodium falciparum is responsible for the most severe forms of human malaria.

6 Aug 2007

FDA approves rapid test for malaria

The U.S. Food and Drug Administration has cleared for marketing the Binax NOW Malaria Test, the first authorized U.S. rapid test for malaria, a mosquito-borne disease caused by a parasite. The test is intended for laboratory use.

27 Jun 2007

More effective treatment for malaria control during pregnancy in Africa

A review of previous studies indicates that two doses of a malaria preventive therapy during pregnancy provides substantial benefit to HIV-negative women in Africa, with more frequent dosing apparently necessary for HIV-positive women, according to an article in the June 20 issue of JAMA.

20 Jun 2007